MarketPulse

clinical trial protocol violations

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Nektar Therapeutics Faces Class Action Over REZOLVE-AA Trial Protocol Violations

Nektar Therapeutics faces class action suit alleging REZOLVE-AA trial protocol violations. Investors urged to act by May 2026 deadline.
NKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Nektar Therapeutics Hit With Class Action Over REZOLVE-AA Trial Integrity Claims

Class action lawsuit alleges Nektar Therapeutics misled investors about REZOLVE-AA trial enrollment standards, claiming executives made false statements about trial integrity.
NKTRsecurities fraudclass action lawsuit